
“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Obama offers plan to deal with the high cost of college
U.S. ex-DEA agent in unlikely new role with pot investment firm
In-Flight Thieves Targeting Airline Travelers’ Carry-On Bags
Bank of Japan vows 'all means available' to smash deflation
VIX Volatility Index Falls to Lowest Level in Over a Year
Fincen Conducting Bank-Style BSA Exams of Virtual Currency Firms
Cat caught smuggling banned cell phones into Russian prison
Marijuana stops child's severe seizures
Shock rockers Insane Clown Posse to sue FBI
Cashless trend is redefining money, and a central bank's role as printer
UK troops deny mutilating Iraq insurgents’ corpses
Texas Comptroller Susan Combs: Debt Excess Even Lives in Texas
Consider keeping Bernanke, top Romney adviser says
How cigarette smuggling fuels Africa’s Islamist violence
Tomorrow’s Advance Man: Marc Andreessen’s plan to win the future